Genmab — September 2017

[Kasper_Gaarde]

CPH, hvilken betydning har det i forhold til det tekniske?

[digafarm]

https://www.investing.com/equities/genmab-technical er altid god som hurtigt overblik hvis man er til det tekniske

[digafarm]

Buy: 9 Sell: 0 Neutral: 0
Summary:
STRONG BUY

[E_L]

would be fun if we could close at 1460, just like last Friday. There is a small open gap there also.

[Legolas23]

Luk i 1458

[Jedi]

Mere medvind til Opdivo https://seekingalpha.com/news/3294374-bristol-myers-opdivo-outperforms-docetaxel-treatment-resistant-lung-cancer-patients-late?app=1&uprof=45&dr=1#email_link - i solide tumorer fungerer PD-1/PD-L1 fint

[E_L]

Here we go: NCT03277105 A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma
https://clinicaltrials.gov/show/NCT03277105

[E_L]

"Herman Sanchez‏ @herman_sanchez -
Dr Robert notes that PD1s/PDL1s might need to be discountinued after response. 2 yr? 1 yr??Interesting. Impact to Pharma value? #esmo2017" https://twitter.com/search?f=tweets&vertical=news&q=%23esmo2017&src=tyah

[E_L]

i think some here share that view. I do.

[E_L]

am I alone here??

[jkj]

(finance.yahoo.com)

[GeorgeBest]

Er tisotumab præsentationen på ESMO nu gået i gang?

[E_L]

haha 2 seconds too early lol, thks jkj

[GeorgeBest]

Tak jkj. Tisotumab præsenteres kl. 17 på ESMO

[jkj]

ja men kun poster i dag den orale er på søndag.

[GeorgeBest]

jeps

[bibob]

Thanks to you E L and jkj. And E L. You will never be alone on this site.

[bibob]

Luk 1456.

[E_L]

[Bulder]

Det er vist omvendt, den orale kl 17 i dag og posteren på søndag - iflg jkj's link